FDA Approves Life-Saving Drug That Helped Orland Park Infant Battling Rare Disease

A major victory for families across the country—and one especially close to home—was announced last Friday as the U.S. Food and Drug Administration (FDA) granted accelerated approval for Forzinity (elamipretide), the first-ever treatment for Barth syndrome, a rare and life-threatening genetic disorder. For one Orland Park family, the news means the difference between hope and […]